Solventum Co. (NYSE:SOLV) Stake Raised by PrairieView Partners LLC

PrairieView Partners LLC grew its holdings in shares of Solventum Co. (NYSE:SOLV) by 3.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,530 shares of the company’s stock after buying an additional 334 shares during the period. PrairieView Partners LLC’s holdings in Solventum were worth $629,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Modus Advisors LLC bought a new stake in Solventum during the fourth quarter worth approximately $25,000. Copeland Capital Management LLC purchased a new position in shares of Solventum during the 3rd quarter valued at $26,000. Stonebridge Financial Group LLC purchased a new position in shares of Solventum during the 4th quarter valued at $26,000. Crews Bank & Trust acquired a new stake in shares of Solventum in the 4th quarter valued at $32,000. Finally, True Wealth Design LLC lifted its stake in shares of Solventum by 23,550.0% in the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company’s stock valued at $33,000 after purchasing an additional 471 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on SOLV shares. Mizuho started coverage on shares of Solventum in a research report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 target price for the company. Piper Sandler upped their price objective on shares of Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a research report on Friday, November 8th. Finally, Morgan Stanley upped their target price on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research note on Monday, November 11th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Solventum has an average rating of “Hold” and a consensus target price of $68.29.

Solventum Stock Down 0.0 %

Shares of NYSE SOLV opened at $73.62 on Thursday. The company’s 50 day simple moving average is $70.51 and its 200 day simple moving average is $68.32. Solventum Co. has a fifty-two week low of $47.16 and a fifty-two week high of $96.05. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.